SEI Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.07M Buy
128,467
+38,263
+42% +$2.66M 0.01% 1251
2025
Q4
$5.99M Sell
90,204
-384,825
-81% -$24.9M 0.01% 1305
2025
Q3
$32M Sell
475,029
-222,646
-32% -$17.6M 0.03% 524
2025
Q2
$60.9M Buy
697,675
+77,767
+13% +$6.1M 0.07% 302
2025
Q1
$42.3M Buy
619,908
+137,120
+28% +$11.2M 0.05% 377
2024
Q4
$37.5M Buy
482,788
+43,391
+10% +$3.21M 0.05% 412
2024
Q3
$29.5M Sell
439,397
-609,987
-58% -$50.1M 0.04% 505
2024
Q2
$119M Sell
1,049,384
-19,447
-2% -$2.46M 0.17% 109
2024
Q1
$148M Sell
1,068,831
-424,523
-28% -$53.4M 0.22% 88
2023
Q4
$185M Buy
1,493,354
+723,709
+94% +$73.9M 0.3% 62
2023
Q3
$71.8M Buy
769,645
+145,528
+23% +$16.4M 0.13% 137
2023
Q2
$80.2M Buy
624,117
+17,122
+3% +$2.07M 0.14% 123
2023
Q1
$70.5M Buy
606,995
+57,269
+10% +$6.41M 0.13% 140
2022
Q4
$62.3M Sell
549,726
-77,417
-12% -$8.5M 0.14% 140
2022
Q3
$50.5M Buy
627,143
+117,373
+23% +$9.94M 0.11% 178
2022
Q2
$38M Buy
509,770
+94,378
+23% +$8.61M 0.08% 262
2022
Q1
$53.4M Sell
415,392
-309,736
-43% -$33.9M 0.11% 180
2021
Q4
$97.4M Sell
725,128
-329,204
-31% -$47.3M 0.18% 98
2021
Q3
$144M Sell
1,054,332
-103,312
-9% -$13M 0.3% 52
2021
Q2
$124M Buy
1,157,644
+37,080
+3% +$3.56M 0.27% 59
2021
Q1
$101M Buy
1,120,564
+486,032
+77% +$45.6M 0.25% 64
2020
Q4
$58.6M Buy
634,532
+340,184
+116% +$30.4M 0.15% 119
2020
Q3
$30.3M Sell
294,348
-212
-0.1% -$22.1K 0.09% 212
2020
Q2
$29.9M Sell
294,560
-98,728
-25% -$8.83M 0.09% 206
2020
Q1
$26.5M Sell
393,288
-51,300
-12% -$3.19M 0.1% 193
2019
Q4
$24.3M Buy
444,588
+376
+0.1% +$17.8K 0.07% 264
2019
Q3
$16.6M Buy
444,212
+71,740
+19% +$2.79M 0.04% 390
2019
Q2
$14M Buy
372,472
+145,632
+64% +$4.58M 0.05% 435
2019
Q1
$6.76M Sell
226,840
-100,380
-31% -$3.53M 0.02% 750
2018
Q4
$11.2M Buy
327,220
+19,144
+6% +$607K 0.04% 495
2018
Q3
$11M Sell
308,076
-290,780
-49% -$9.01M 0.04% 481
2018
Q2
$14.2M Buy
598,856
+151,620
+34% +$3.21M 0.05% 416
2018
Q1
$8.29M Buy
447,236
+36,044
+9% +$533K 0.03% 590
2017
Q4
$5.9M Sell
411,192
-1,288,632
-76% -$16.8M 0.02% 832
2017
Q3
$20.8M Sell
1,699,824
-626,856
-27% -$11.1M 0.07% 300
2017
Q2
$42.5M Buy
2,326,680
+373,992
+19% +$6.91M 0.17% 124
2017
Q1
$41.4M Buy
1,952,688
+90,388
+5% +$1.76M 0.18% 119
2016
Q4
$27.8M Buy
1,862,300
+624,340
+50% +$11.1M 0.13% 162
2016
Q3
$27.1M Buy
1,237,960
+683,936
+123% +$15.2M 0.14% 168
2016
Q2
$11M Buy
554,024
+491,776
+790% +$8.37M 0.07% 375
2016
Q1
$1.06M Sell
62,248
-546,400
-90% -$9.13M 0.01% 1137
2015
Q4
$12.5M Sell
608,648
-19,048
-3% -$396K 0.08% 325
2015
Q3
$13.5M Buy
627,696
+132,032
+27% +$2.95M 0.12% 193
2015
Q2
$9.91M Buy
495,664
+365,836
+282% +$6.43M 0.09% 262
2015
Q1
$2.02M Sell
129,828
-8,860
-6% -$134K 0.02% 728
2014
Q4
$1.91M Buy
+138,688
New +$1.7M 0.02% 721

Other funds holding DXCM

SEI Investments's DXCM Position: Q1 2026 in Review

SEI Investments increased its DexCom (DXCM) stake by 42% in Q1 2026, buying an estimated $2.66M and bringing the position to 128,467 shares worth $8.07M. The position accounts for 0.01% of the portfolio, ranked #1251.

SEI Investments first reported a position in DXCM in Q4 2014 and has held it in 46 quarters since. The position peaked at $185M in Q4 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • SEI Investments held 128,467 shares of DexCom worth $8.07M as of Q1 2026.
  • SEI Investments bought 38,263 DexCom shares in Q1 2026, an estimated $2.66M.
  • DexCom made up 0.01% of SEI Investments's portfolio in Q1 2026, its #1251 holding.
  • SEI Investments first reported a position in DexCom in Q4 2014 and has held it in 46 quarters since.
  • SEI Investments's DexCom position peaked at $185M in Q4 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.